Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar

Insilico Medicine launches Pharma AI Spring Kickoff 2026 webinar

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science. To explore these advancements, Insilico Medicine (03696.HK), a clinical-stage generative AI–driven drug discovery company, today announced that the Pharma.AI Spring Kickoff 2026 will be held…

Global Artificial Intelligence (AI) in Precision Medicine Market to Attain USD 10.32 Billion by 2032, Witnessing a CAGR of 31.35%, Says MarkNtel Advisors

Global Artificial Intelligence (AI) in Precision Medicine Market to Attain USD 10.32 Billion by 2032, Witnessing a CAGR of 31.35%, Says MarkNtel Advisors

NEW DELHI, March 25, 2026 /PRNewswire/ — According to the in-depth study published by MarkNtel Advisors, the Global Artificial Intelligence (AI) in Precision Medicine Market is projected to grow at a CAGR of around 31.35% during 2026-2032. The market expansion is primarily driven by the increasing integration of artificial intelligence in healthcare, rising demand for…